Suchergebnisse - "Mauss, Stefan"

PubPharm (17)

1

A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress

enthalten in: Archives of virology | 2020

von Cázares-Cortazar, A. | Uribe-Noguez, L. | Mata-Marín, J. | +6

2

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2020

von Uribe-Noguez, L. | Mata-Marín, J. | Ocaña-Mondragón, A. | +7

3

Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back

enthalten in: AIDS (London, England) | 2019

von Milinkovic, A. | Berger, F. | Arenas-Pinto, A. | +1

4

Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease : real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)

enthalten in: European journal of gastroenterology & hepatology | 2019

von Wiegand, J. | Buggisch, P. | Mauss, S. | +10

5

Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Maasoumy, B. | Buggisch, P. | Mauss, S. | +9

CommentIn: Liver Int. 2018 Dec;38(12):2342-2342.. - PMID 30218615

6

Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2017

von Tacke, F. | Günther, R. | Buggisch, P. | +9

CommentIn: Liver Int. 2017 Aug;37(8):1252-1253. - PMID 28380274

7

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2) : a multicentre, open-label, non-randomised, phase 3 study

enthalten in: Lancet (London, England) | 2015

von Molina, J. | Orkin, C. | Iser, D. | +52

CommentIn: Lancet. 2015 Mar 21;385(9973):1052-4. - PMID 25659286

8

SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Dieterich, D. | Asselah, T. | Guyader, D. | +12

9

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

enthalten in: The New England journal of medicine | 2014

von Afdhal, N. | Zeuzem, S. | Kwo, P. | +121

CommentIn: Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):329. - PMID 24776807

10

Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice

enthalten in: European journal of gastroenterology & hepatology | 2014

von Niederau, C. | Mauss, S. | Böker, K. | +7